Nubeqa

Darolutamide

6.6 Moderate risk

Nubeqa & Prostatic specific antigen increased

18.0%

of users reported Prostatic specific antigen increased

92.3%

also reported Severe reaction

100.0%

are men

Most common medical consequences

Severe reaction
92.3%
Hospitalization
7.7%

Have you experienced any negative side effects from this medication?

Nubeqa: general information

Most common side effects (10)

Most commonly affected ages

60 - 69 years
12.4%
70 - 79 years
35.8%
80 - 89 years
51.7%